The present specification discloses Ranpirnase and Amphinase, compositions comprising Ranpirnase and/or Amphinase, and methods and uses to treat a viral conjunctivitis, an epidemic keratoconjunctivitis, and/or a pharyngoconjunctival fever, reduce or suppress a level of virus or viral titer, reduce or suppress viral replication, reduce or suppress protein synthesis, reduce or suppress a level of a tRNA, reduce or suppress a level of an inflammation inducing molecule and/or an inflammation inducing prostaglandin, stimulate or enhance a peroxisome proliferator-activated receptor (PPAR) pathway signal, promote the resolving phenotypic change of M1 to M2, modulate Th1 and Th2 cytokines, and/or reduce or suppress a NF.kappa.B pathway signal using Ranpirnase, Amphinase or compositions comprising Ranpirnase and/or Amphinase.

keratoconjunctivitis/fever

Viral conjunctivitis treatment using Ranpirnase and/or Amphinase

کاملترین پایگاه داده گیاهان دارویی با پشتیبانی علمی